GlaxoSmithKline: Rhinitis trials

The registry lists 25 Rhinitis studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 1 6Phase 2 8Phase 3 4Phase 4 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)CompletedNCT03555890Phase 1Results posted
• Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958CompletedNCT02446613Phase 2Results posted
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)CompletedNCT02424539Phase 4Results posted
• Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal SpraysCompletedNCT02397915Phase 4Results posted
• A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)CompletedNCT01957202Phase 2Results posted
• A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic RhinitisCompletedNCT01949051Phase 2Results posted
• A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic RhinitisCompletedNCT01916226Phase 4Results posted
• Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01622231Phase 3Results posted
• Safety Study of Levocetirizine Oral Solution for Japanese PediatricsCompletedNCT01563081Phase 3Results posted
• SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic RhinitisCompletedNCT01424514Phase 2Results posted
• Intranasal SB-705498 in Allergic Rhinitis (AR) PatientsCompletedNCT01424397Phase 2Results posted
• Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting ConditionsCompletedNCT02658422Phase 1
• A Relative Bioavailability Study of Fluticasone Furoate and LevocabastineCompletedNCT01962467Phase 1
• Pharmacokinetic Study of Levocetirizine Oral SolutionCompletedNCT01622283Phase 1
• A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory AllergiesCompletedNCT01607372Phase 2
• A Study to Investigate the Effect of SB-705498 on Chronic CoughCompletedNCT01476098Phase 2
• Drug Use Investigation for XYZAL®CompletedNCT01445262
• Intranasal SB-705498 in Non-allergic Rhinitis PatientsCompletedNCT01439308Phase 2
• Special Drug Use Investigation for ALLERMIST (Long Term)CompletedNCT01420822
• Drug Use Investigation for ALLERMISTCompletedNCT01376206
• Regulatory AVAMYS Nasal Spray PMSCompletedNCT01001130
• Intranasal SB-705498 in Healthy VolunteersCompletedNCT00907933Phase 1
• A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge ModelCompletedNCT00731250Phase 1
• Study Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00253058Phase 3
• Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3